MAGI Regional Clinical Trial Agreement Requirements

Please send us corrections, additions and deletions.

Display by:
CTA section Region  
Section:
  

France
Requirement:
Laboratory may request/require separate bipartite CTA (Laboratory Manager and Sponsor/CRO) even if it is part of a hospital site.
Source:
Anonymous

France
Requirement:
For private sites, usually bipartite CTA (PI and Sponsor/CRO), and sometimes? tripartite CTA (PI, PI's Association, and Sponsor/CRO). Association's president/treasurer/secretary signs.
Source:
Anonymous

France
Requirement:
Hospital pharmacy may request/require? a separate agreement if Sponsor/CRO requires destruction of unused study drug.
Source:
Anonymous

France
Requirement:
Hospitals require tripartite CTA (PI, hospital and sponsor/CRO) or 4-party CTA, including hospital association
Source:
Anonymous

France
Requirement:
Hospitals may request/require? a separate? tripartite CTA (PI, Institution and Sponsor/CRO) to cover pharmacy, lab, study-specific exam (e.g., X-Ray) and/or administrative costs.
Source:
Anonymous

Germany
Requirement:
If CTA is between site and CRO, some sites request/require? additional short CTA with Sponsor.
Source:
Anonymous

Germany
Requirement:
Separate agreement with site/hospital/institution. Separate agreement with PI. Separate agreement with pharmacy, even if in hospital. Sometimes separate ageement with lead PI in Germany. Sometimes with study nurse.
Source:
Anonymous

Germany
Requirement:
Single CTA. Institution signs. Principal Investigator sometimes signs.
Source:
Anonymous

Greece
Requirement:
CTA with institution. No separate investigator or pharmacy agreement required.
Source:
Anonymous

India
Requirement:
Single CTA. Institution sometimes signs. Principal Investigator sometimes signs.
Source:
Anonymous


Page 2 of 5 with results 11-20 of 42.    First  Previous  Next  Last

© This information is not legal or regulatory advice, and may not be accurate. Consult with your legal and regulatory advisors.

© 2004-2014 MAGI.  Trademark Notice  Terms & Conditions  Privacy Statement  Site Map